Effect of a compound unani formulation, applied locally, in patients suffering from wrist pain and numbness.

Clinical Study on the Effect of Roghan-e-Qust in Carpal Tunnel Syndrome

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/03/024071

Enrollment

Registered

2020-03-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G560- Carpal tunnel syndrome

Interventions

Intervention1: Roghan-e-Qust: Qust (Saussurea lappa) 120g, Filfl siyah (Piper nigram)120g, Aaqarqarha (Anacyclus pyrethrum) 120g, Farfiyun (Euphorbia antiquorum) 120g, Jund Bedastar (Castoreum) 20g, R

Eligibility

Inclusion criteria

Inclusion criteria: 1. Positive Phalenâ??s test 2. Positive Tinels sign 3. Positive Durkanâ??s signs

Exclusion criteria

Exclusion criteria: 1. Thenar atropy 2. Negative Phalenâ??s test 3. Negative Tinels sign 4. Negative Durkanâ??s signs 5. Pregnant and lactating mothers

Design outcomes

Primary

Measure	Time frame
1. Pain VAS(Visual Analogue Scale) 2. BOSTON Carpal Tunnel Syndrome QuestionnaireTimepoint: 0, 5th, 10th and 15th day	—

Secondary

Measure	Time frame
Not ApplicableTimepoint: Not Applicable	—

Countries

India

Contacts

Public ContactMohamed Rasheed Fathima Raziya

National Institute Of Unani Medicine

drmaquamri@gmail.com9341072974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026